-
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
-
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.
-
The move comes just days before a U.S. rule was set to go into effect allowing for bulk importation of drugs from Canada. Trump promised it would lower costs and be a "game changer" for seniors.
-
Industry experts say Florida is likely to be the first state to win federal approval for a drug importation plan — something that could occur before the November election.
-
Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug.
-
With drug costs on the rise — and insurers refusing to cover some prescriptions — even patients with insurance can find themselves facing high out-of-pocket costs or going without.
-
Skyrocketing prices of insulin in recent years have increased medical costs for the millions of people living with diabetes around the country and in…
-
Lawmakers are back on Capitol Hill on Monday after an extended summer recess. Debates on gun control, prescription drugs and trade are expected, but bipartisan cooperation on those are elusive.
-
Florida’s initial effort to gauge interest in the operation of a Canadian drug importation program has drawn more letters of concern from critics than...
-
A new law would let the state make bulk purchases of prescription drugs from Canada. But it still faces hurdles that could keep it from becoming reality.
-
Floridians spend a lot on prescription drugs -- more than $30 billion last year, according to the Kaiser Family Foundation. Now at least some Florida…
-
A Senate health care panel ran out of time Thursday and was unable to consider a measure aimed at allowing imported prescription drugs from Canada.